Jefferies Group LLC Kymera Therapeutics, Inc. Transaction History

Jefferies Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$35.64 - $85.46 $178,200 - $427,299	-5,000 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$28.07 - $87.83 $140,350 - $439,150	5,000 New	5,000 $310,000
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $140,350 - $439,150	5,000 New	5,000 $310,000

183

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.09B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.